Recent studies showed that treatment with histone deacetylase inhibitors such as SAHA and trichostatin A strongly inhibited the migration and invasion of breast and prostate cancer cells and caused an upregulation of E-cadherin [48,49]. The gene discussed is CDH1; the disease is prostate carcinoma.